PunitaGuptaMD
Medical Genetics • Paterson, NJClinical Genetics
Clinical Assistant Professor of Pediatrics NYMC, Chief Division of Genetics, Medical Director Lysosomal Storage Disease Center, Co-Medical Director Alfiero & Lucia Palestroni Center, St. Joseph’s Children’s Hospital
Dr. Gupta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
St. Joseph's University Medical Center
703 Main St.
Paterson, NJ 07503Phone+1 973-754-2727
Education & Training
NYU Grossman School of MedicineFellowship, Neurogenetics, 2012 - 2013
New York Presbyterian Hospital (Columbia Campus)Residency, Medical Genetics and Genomics, 2010 - 2012
University of Illinois College of Medicine at ChicagoResidency, Pediatrics, 2007 - 2010
M.S. Ramaiah Medical CollegeClass of 2002
Certifications & Licensure
NJ State Medical License 2013 - 2025
NY State Medical License 2012 - 2014
IL State Medical License 2007 - 2011- American Board of Pediatrics Pediatrics
- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Publications & Presentations
PubMed
- 21 citationsThe diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?Neal J Weinreb, Ozlem Goker-Alpan, Priya S Kishnani, Nicola Longo, T Andrew Burrow
Molecular Genetics and Metabolism. 2022-05-01 - 16 citationsPharmacological treatment of pediatric Gaucher disease.Punita Gupta, Gregory M. Pastores
Expert Review of Clinical Pharmacology. 2018-12-03 - 28 citationsTransforming the clinical outcome in CRIM-negative infantile Pompe disease identified via newborn screening: the benefits of early treatment with enzyme replacement th...Cindy Li, Ankit K. Desai, Punita Gupta, Katherine Dempsey, Vikas Bhambhani
Genetics in Medicine. 2021-01-25
Press Mentions
Transforming the Clinical Outcome in CRIM-Negative Infantile Pompe Disease Identified via Newborn Screening: The Benefits of Early Treatment with Enzyme Replacement Therapy and Immune Tolerance InductionJanuary 25th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
